Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Rickels

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Expert Opinion on Pharmacotherapy|June 24, 2004
Alprazolam extended-release in panic disorderKarl Rickels
Psychotherapy and Psychosomatics|September 25, 2013
Should benzodiazepines be replaced by antidepressants in the treatment of anxiety disorders? Fact or fiction?Karl Rickels
The American Journal of Psychiatry|September 10, 2010
Medication guesses in double-blind studiesKarl Rickels
Plos Medicine|February 24, 2006
Consumer advertising can be misleadingKarl Rickels
Psychotherapy and Psychosomatics|May 28, 2016
The Items Predicting Non-Remission after 6 Months of Treatment of Patients with Generalized Anxiety Disorder Covered the Eysenck Neuroticism Components of Anxiety, Interpersonal Sensitivity and DepressionPer Bech, Karl Rickels
The Journal of Clinical Psychiatry|February 4, 2003
Pharmacotherapy of generalized anxiety disorderKarl Rickels, Moira Rynn
Expert Opinion on Pharmacotherapy|July 11, 2015
Pharmacological treatment for generalized anxiety disorder in adults: an updateJennifer A Reinhold, Karl Rickels
Journal of Clinical Psychopharmacology|October 19, 2017
Antidepressant Trials: Are the Diminishing Effect Sizes of Efficacy Trials Avoidable?Karl Rickels, Donald S Robinson
Expert Opinion on Pharmacotherapy|August 2, 2008
Desvenlafaxine succinate for the treatment of major depressive disorderFalk W Lohoff, Karl Rickels
Journal of Clinical Psychopharmacology|June 11, 2009
Comments on "Clinical trials of antidepressants: time to shift to a new model" by Dr KatzKarl Rickels, Donald S Robinson
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Expert Opinion on Pharmacotherapy|June 24, 2004
Alprazolam extended-release in panic disorderKarl Rickels
Psychotherapy and Psychosomatics|September 25, 2013
Should benzodiazepines be replaced by antidepressants in the treatment of anxiety disorders? Fact or fiction?Karl Rickels
The American Journal of Psychiatry|September 10, 2010
Medication guesses in double-blind studiesKarl Rickels
Plos Medicine|February 24, 2006
Consumer advertising can be misleadingKarl Rickels
Psychotherapy and Psychosomatics|May 28, 2016
The Items Predicting Non-Remission after 6 Months of Treatment of Patients with Generalized Anxiety Disorder Covered the Eysenck Neuroticism Components of Anxiety, Interpersonal Sensitivity and DepressionPer Bech, Karl Rickels
The Journal of Clinical Psychiatry|February 4, 2003
Pharmacotherapy of generalized anxiety disorderKarl Rickels, Moira Rynn
Expert Opinion on Pharmacotherapy|July 11, 2015
Pharmacological treatment for generalized anxiety disorder in adults: an updateJennifer A Reinhold, Karl Rickels
Journal of Clinical Psychopharmacology|October 19, 2017
Antidepressant Trials: Are the Diminishing Effect Sizes of Efficacy Trials Avoidable?Karl Rickels, Donald S Robinson
Expert Opinion on Pharmacotherapy|August 2, 2008
Desvenlafaxine succinate for the treatment of major depressive disorderFalk W Lohoff, Karl Rickels
Journal of Clinical Psychopharmacology|June 11, 2009
Comments on "Clinical trials of antidepressants: time to shift to a new model" by Dr KatzKarl Rickels, Donald S Robinson
Pageof 7